From: An update on vitamin B12-related gene polymorphisms and B12 status
| Chromosome location | Gene name (gene symbol) | Reference SNP cluster ID | Sample size and ethnicity | Study design | Age (years) | Minor allele frequency | Effect size | P value | References |
|---|---|---|---|---|---|---|---|---|---|
| 1p34.1 | Methylmalonic aciduria and homocystinuria type C protein (MMACHC) | rs10789465 | n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | C = 0.469† | Not available | 1.00 × 10−3 | Andrew et al. [13] |
| 1p36.3 | Methylenetetrahydrofolate Reductase (MTHFR) | rs1801131 |
n = 988 French women | Cross-sectional | 40–65 (range) | C = 0.290 | Not available | > 0.05 | De Batlle et al. [79] |
| 1p36.3 | Methylenetetrahydrofolate reductase (MTHFR) | Rs1801131 |
n = 6784 Danish | Cross-sectional | 30–60 (range) | C = 0.340 | Not available | > 0.05 | Thuesen et al. [57] |
| 1p36.3 | Methylenetetrahydrofolate Reductase (MTHFR) | Rs1801131 |
n = 220 Brazilian | Cross-sectional | 1–8 (range) | C = 0.240 | Not available | > 0.05 | Aléssio et al. [78] |
| 1p36.3 | Methylenetetrahydrofolate Reductase (MTHFR) | rs1801133 |
n = 988 French women | Cross-sectional | 40–65 (range) | T = 0.360 | Not available | > 0.05 | De Batlle et al. [79] |
| 1p36.3 | Methylenetetrahydrofolate Reductase (MTHFR) | rs1801133 |
n = 731 English (White Caucasian) | Cross-sectional | 85 | T = 0.330 | β = 5.00 × 10−5 pmol/l‡ | > 0.05 | Mendonca et al. [28] |
| 1p36.3 | Methylenetetrahydrofolate Reductase (MTHFR) | rs1801133 |
Elderly individuals: n = 262 Brazilian | Cross-sectional |
60–91 (range) | T = 0.370 | Not available | > 0.05 | Barnabe et al. [77] |
|
Children: n = 106 Brazilian |
0.5–6 (range) | T = 0.290 | Not available | > 0.05 | |||||
| 1p36.3 | Methylenetetrahydrofolate Reductase (MTHFR) | rs1801133 |
n = 6784 Danish | Cross-sectional |
30–60 (range) | T = 0.290 |
Effect allele: Not available Other allele: not available Low serum vitamin B12: OR 1·78 (95% CI 1.25, 2.54) pmol/l | 3.00 × 10−3 | Thuesen et al. [57] |
| 1p36.3 | Methylenetetrahydrofolate Reductase (MTHFR) | rs1801133 |
n = 153 Spanish | Cross-sectional |
13–19 (range) | T = 0.380 | Not available | > 0.05 | Al-Tahan et al. [81] |
| 1p36.3 | Methylenetetrahydrofolate Reductase (MTHFR) | rs1801133 |
n = 10,601 Norwegian | Cross-sectional | 56 | T = 0.280 | Not available | > 0.05 | Hustad et al. [80] |
| 1p36.3 | Methylenetetrahydrofolate Reductase (MTHFR) | rs1801133 |
n = 220 Brazilian | Cross-sectional |
1–8 (range) | T = 0.320 | Not available | > 0.05 | Aléssio et al. [78] |
| 1q43 | 5-Methyltetrahydrofolate-Homocysteine methyltransferase (MTR) | rs1805087 |
n = 731 English (White Caucasian) | Cross-sectional | 85 | G = 0.180 | β = 4.00 × 10−3 pmol/l‡ | > 0.05 | Mendonca et al. [28] |
| 1q43 | 5-Methyltetrahydrofolate-Homocysteine methyltransferase (MTR) | rs1805087 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.161† | Not available | > 0.05 | Andrew et al. [13] |
| 1q43 | 5-Methyltetrahydrofolate-Homocysteine methyltransferase (MTR) | rs1805087 |
n = 6784 Danish | Cross-sectional |
30–60 (range) | G = 0.200 | Not available | > 0.05 | Thuesen et al. [57] |
| 1q43 | 5-Methyltetrahydrofolate-Homocysteine methyltransferase (MTR) | rs2275568 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | A = 0.460† | Not available | > 0.05 | Andrew et al. [13] |
| 1q43 | 5-Methyltetrahydrofolate-Homocysteine methyltransferase (MTR) | rs2789352 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | T = 0.381† | Not available | > 0.05 | Andrew et al. [13] |
| 1q43 | 5-Methyltetrahydrofolate-Homocysteine methyltransferase (MTR) | rs3768142 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.384† | Not available | > 0.05 | Andrew et al. [13] |
| 1q43 | 5-Methyltetrahydrofolate-homocysteine methyltransferase (MTR) | rs10733118 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | T = 0.381† | Not available | > 0.05 | Andrew et al. [13] |
| 1q43 | 5-Methyltetrahydrofolate-Homocysteine methyltransferase (MTR) | rs10925257 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.155† | Not available | > 0.05 | Andrew et al. [13] |
| 1q43 | 5-Methyltetrahydrofolate-homocysteine methyltransferase (MTR) | rs11800413 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.431† | Not available | > 0.05 | Andrew et al. [13] |
| 1q43 | 5-Methyltetrahydrofolate-homocysteine methyltransferase (MTR) | rs12060264 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | A = 0.438† | Not available | > 0.05 | Andrew et al. [13] |
| 2q23.2 | Methylmalonic aciduria and homocystinuria,CblD type (MMADHC) | rs7580915 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.228† | Not available | > 0.05 | Andrew et al. [13] |
| 4p14 | Replication factor C subunit 1 (RFC1) | rs1051266 |
Elderly individuals: n = 262 Brazilian | Cross-sectional |
60–91 (range) | A = 0.430 | Not available | > 0.05 | Barnabe et al. [77] |
|
Children: n = 106 Brazilian |
1–6 (range) | A/G = 0.500 | Not available | > 0.05 | |||||
| 4q31.21 | Methylmalonic aciduria (cobalamin deficiency) cblA type (MMAA) | rs4835011 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.080† | Not available | > 0.05 | Andrew et al. [13] |
| 4q31.21 | Methylmalonic aciduria (cobalamin deficiency) cblA type (MMAA) | rs4835012 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.178† | Not available | 3.00 × 10−2 | Andrew et al. [13] |
| 4q31.21 | Methylmalonic aciduria (cobalamin deficiency) cblA type (MMAA) | rs4835014 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | T = 0.031† | Not available | > 0.05 | Andrew et al. [13] |
| 4q31.21 | Methylmalonic aciduria (cobalamin deficiency) cblA type (MMAA) | rs11728906 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.235† | Not available | > 0.05 | Andrew et al. [13] |
| 5q14.1 | Betaine-homocysteine S-methyltransferase (BHMT) | rs3733890 |
n = 6784 Danish | Cross-sectional |
30–60 (range) | A = 0.290 | Not available | > 0.05 | Thuesen et al. [57] |
| 5p15.31 | Methionine synthase reductase (MTRR) | rs10380 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | T = 0.156† | Not available | > 0.05 | Andrew et al. [13] |
| 5p15.31 | Methionine synthase reductase (MTRR) | rs162031 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | T = 0.205† | Not available | > 0.05 | Andrew et al. [13] |
| 5p15.31 | Methionine synthase reductase (MTRR) | rs162036 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.186† | Not available | 4.00 × 10−2 | Andrew et al. [13] |
| 5p15.31 | Methionine synthase reductase (MTRR) | rs162040 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | C = 0.124† | Not available | > 0.05 | Andrew et al. [13] |
| 5p15.31 | Methionine synthase reductase (MTRR) | rs162048 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.164† | Not available | 5.00 × 10−2 | Andrew et al. [13] |
| 5p15.31 | Methionine synthase reductase (MTRR) | rs326120 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.155† | Not available | > 0.05 | Andrew et al. [13] |
| 5p15.31 | Methionine synthase reductase (MTRR) | rs1532268 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | A = 0.308† | Not available | 1.00 × 10−2 | Andrew et al. [13] |
| 5p15.31 | Methionine synthase reductase (MTRR) | rs1801394 |
n = 6784 Danish | Cross-sectional |
30–60 (range) | A = 0.430 | Not available | > 0.05 | Thuesen et al. [57] |
| 5p15.31 | Methionine synthase reductase (MTRR) | rs1801394 |
n = 220 Brazilian | Cross-sectional | 1–8 (range) | A = 0.490 | Not available | > 0.05 | Aléssio et al. [78] |
| 5p15.31 | Methionine synthase reductase (MTRR) | rs2966952 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | T = 0.167† | Not available | > 0.05 | Andrew et al. [13] |
| 5p15.31 | Methionine synthase reductase (MTRR) | rs3776455 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.389† | Not available | 2.00 × 10−3 | Andrew et al. [13] |
| 5p15.31 | Methionine synthase reductase (MTRR) | rs6555501 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | C = 0.473† | Not available | > 0.05 | Andrew et al. [13] |
| 6p12.3 | Methylmalonyl-CoA mutase (MUT) | rs6458687 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | T = 0.372† | Not available | > 0.05 | Andrew et al. [13] |
| 6p12.3 | Methylmalonyl-CoA mutase (MUT) | rs6458690 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.363† | Not available | 2.00 × 10− 4 | Andrew et al. [13] |
| 6p12.3 | Methylmalonyl-CoA mutase (MUT) | rs9381784 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | T = 0.363† | Not available | 3.00 × 10−2 | Andrew et al. [13] |
| 6q13 | LMBR1 domain containing 1 (LMBRD1) | rs991974 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | T = 0.044† | Not available | > 0.05 | Andrew et al. [13] |
| 6q13 | LMBR1 domain containing 1 (LMBRD1) | rs1457498 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | T = 0.084† | Not available | > 0.05 | Andrew et al. [13] |
| 6q13 | LMBR1 domain containing 1 (LMBRD1) | rs3778241 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | T = 0.398† | Not available | > 0.05 | Andrew et al. [13] |
| 6q13 | LMBR1 domain containing 1 (LMBRD1) | rs3799105 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | C = 0.384† | Not available | > 0.05 | Andrew et al. [13] |
| 6q13 | LMBR1 domain containing 1 (LMBRD1) | rs6455338 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | C = 0.387† | Not available | > 0.05 | Andrew et al. [13] |
| 6q13 | LMBR1 domain containing 1 (LMBRD1) | rs9294851 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | T = 0.384† | Not available | > 0.05 | Andrew et al. [13] |
| 11q12.1 | Transcobalamin 1 (TCN1) | rs526934 |
n = 731 English (White Caucasian) | Cross-sectional | 85 | G = 0.270 | β = 4.00 × 10−3 pmol/l‡ | > 0.05 | Mendonca et al. [28] |
| 12q24.11 | Methylmalonic aciduria (cobalamin deficiency) cblB type (MMAB) | rs2287182 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | A = 0.128† | Not available | > 0.05 | Andrew et al. [13] |
| 12q24.11 | Methylmalonic aciduria (cobalamin deficiency) cblB type (MMAB) | rs3759387 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | A = 0.235† | Not available | > 0.05 | Andrew et al. [13] |
| 12q24.11 | Methylmalonic aciduria (cobalamin deficiency) cblB type (MMAB) | rs7134594 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | C = 0.487† | Not available | > 0.05 | Andrew et al. [13] |
| 12q24.11 | Methylmalonic aciduria (cobalamin deficiency) cblB type (MMAB) | rs7957619 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | A = 0.110 † | Not available | > 0.05 | Andrew et al. [13] |
| 12q24.11 | Methylmalonic aciduria (cobalamin deficiency) cblB type (MMAB) | rs12314392 |
n = 262 Caucasian women of North European descent | Cross-sectional (Twin Study) | 48 ± 13 | G = 0.433 † | Not available | > 0.05 | Andrew et al. [13] |
| 19p13.2 | CD320 molecule (CD320)/transcobalamin II receptor (TcblR) | rs2336573 |
n = 591 Caucasian women | Cross-sectional | 77 ± 7 | A = 0.050 | Not available | > 0.05 | Kurnat-Thoma et al. [59] |
|
n = 198 African American women | 75 ± 6 | A = 0.330 | Not available | 4.0 × 10−2 | |||||
|
n = 797 Combined total | Not available | 2.0 × 10−2 | |||||||
| 19q13.33 | Fucosyl transferase 2 gene (FUT2) | rs492602 |
n = 731 English (White Caucasian) | Cross-sectional | 85 | A = 0.450 | β = 0.05 pmol/l‡ | < 0.001 | Mendonca et al. [28] |
| 19q13.33 | Fucosyl transferase 2 gene (FUT2) | rs602662 |
Vegetarian: n = 553 North Indian | Cross-sectional |
50 (41–59) Median (interquartile range) | A = 0.310 |
Effect: A allele Other: G allele β = 0.12 pmol/l | 5.0 × 10−3 | Tanwar et al. [27] |
|
Non-vegetarian: n = 593 North Indian | Cross-sectional |
47 (37–55) Median (interquartile range) |
Effect: A allele Other: G allele β = 0.12 pmol/l | 4.0 × 10−3 | |||||
|
Combined total: n = 1146 North Indian | Cross-sectional |
49 (40–57) Median (interquartile range) |
Effect: A allele Other: G allele β = 0.12 pmol/l | 4.0 × 10−5 | |||||
| 22q12.2 | Transcobalamin 2 (TCN2) | rs1801198 |
NORCAP cohort*: n = 2411 Norwegian Serum holoTC could be analysed in only 2379 individuals | Cross-sectional |
50–64 (range) | G = 0.440 |
Effect: C allele Other: G allele Total holo-TC: β = 0.02 pmol/l‡ | > 0.05‡ | Riedel et al. [55] |
|
Effect: C allele Other: G allele Plasma Cbl: β = 0.03 pmol/l‡ | > 0.05‡ | ||||||||
| 22q12.2 | Transcobalamin 2 (TCN2) | rs1801198 |
n = 122 Portuguese | Cross-sectional | 46 ± 13 | G = 0.480 | Not available |
Vitamin B12: > 0.05 Holo-TC: < 0.05 | Castro et al. [52] |
| 22q12.2 | Transcobalamin 2 (TCN2) | rs1801198 |
n = 554 Participants of Latino ancestry residing in USA | Cross-sectional | 69 ± 6 | G = 0.350 | Not available |
Vitamin B12: > 0.05 Total holo TC: > 0.05 | Garrod et al. [56] |
| 22q12.2 | Transcobalamin 2 (TCN2) | rs1801198 |
n = 613 Northern Irish Men (Caucasian) | Cross-sectional |
30–49 (range) | G = 0.450 | Not available | 1.00 × 10−2 | Stanislawska-Sachadyn et al. [54] |
| 22q12.2 | Transcobalamin 2 (TCN2) | rs1801198 |
n = 6784 Danish | Cross-sectional |
30–60 (range) | G = 0.440 | Not available | > 0.05 | Thuesen et al. [57] |
| 22q12.2 | Transcobalamin 2 (TCN2) | rs1801198 |
n = 207 Brazillian | Cross-sectional |
1–8 (range) | G = 0.360 | Not available | > 0.05 | Alessio et al. [58] |
| 22q12.2 | Transcobalamin 2 (TCN2) | rs4820888 |
n = 591 Caucasian women | Cross-sectional | 77 ± 7 | G = 0.430 | Not available | > 0.05 | Kurnat-Thoma et al. [59] |
|
n = 198 African American women | 75 ± 6 | G = 0.450 | Not available | > 0.05 | |||||
|
n = 797 Combined total | Not available | 2.0 × 10−2 | |||||||
| 22q12.2 |
Transcobalamin 2 (TCN2) | rs9606756 |
NORCAP cohort*: n = 2411 Norwegian Serum holoTC could be analysed in only 2379 individuals | Cross-sectional |
50–64 (range) | G = 0.120 |
Effect: A allele Other: G allele Total holo-TC: β = − 0.21 pmol/l‡ | < 0.001‡ | Riedel et al. [55] |
|
Effect: A allele Other: G allele Plasma Cbl: β = −0.02 pmol/l‡ | > 0.05‡ | ||||||||
| 22q12.2 | Transcobalamin 2 (TCN2) | rs9606756 |
n = 6784 Danish | Cross-sectional |
30–60 (range) | G = 0.120 | Not available | > 0.05 | Thuesen et al. [57] |
|
1p36.3 19q13.33 | Methylenetetrahydrofolate Reductase (MTHFR) + Fucosyl transferase 2 gene (FUT2) |
rs180133 rs180131 rs492602 |
n = 988 Brazillian | Cross-sectional | 5 ± 3 |
rs180133 T = 0.320 rs180131 C = 0.220 rs492602 G = 0.390 | β for GRS = − 0·11 pmol/l | < 0·001 | Cobayashi et al. [105] |